Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1
Crossref DOI link: https://doi.org/10.1007/s12032-017-1011-5
Published Online: 2017-09-06
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gupta, Pramodkumar P.
Bastikar, Virupaksha A.
Kuciauskas, Dalius
Kothari, Shanker Lal
Cicenas, Jonas
Valius, Mindaugas http://orcid.org/0000-0001-8478-8517
Funding for this research was provided by:
Lietuvos Mokslo Taryba (MIP-033/2014)
License valid from 2017-09-06